(Q34550581)

3 August 2017

1 reference

title

Brivudin (bromovinyl deoxyuridine). (English)

1 reference

3 August 2017

3

David P Figgitt

1 reference

3 August 2017

Susan J Keam

1

1 reference

PubMed ID

15341504

3 August 2017

Therese M Chapman

series ordinal

2

1 reference

3 August 2017

1 January 2004

1 reference

3 August 2017

1 reference

3 August 2017

64

1 reference

3 August 2017

2091-7; discussion 2098-9

1 reference

3 August 2017

18

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464180-00011

3 August 2017

0 references

cites work

Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus

1 reference

12 December 2020

Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia

1 reference

12 December 2020

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

1 reference

12 December 2020

Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains

1 reference

12 December 2020

Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing

1 reference

12 December 2020

Antiviral therapy of herpes simplex and varicella-zoster virus infections

1 reference

12 December 2020

Potent inhibitory effects of the 5'-triphosphates of (E)-5-(2-bromovinyl)-2'-deoxyuridine and (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on DNA polymerase gamma

1 reference

12 December 2020

The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster

1 reference

12 December 2020

Herpes zoster and postherpetic neuralgia. Optimal treatment

1 reference

12 December 2020

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study

1 reference

12 December 2020

The identification of risk factors associated with persistent pain following herpes zoster.

1 reference

12 December 2020

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

1 reference

12 December 2020

Herpes zoster guidelines of the German Dermatological Society

1 reference

12 December 2020

Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.

1 reference

12 December 2020

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus

1 reference

12 December 2020

10.2165/00003495-200464180-00011

Identifiers

DOI

1 reference

PubMed ID

15341504

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

15341504